Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameUni Medical
Stock Code02666
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities向醫院客戶提供一系列綜合醫療服務,包括設備融資(以融資租賃服務方式提供)、醫療行業、設備及融資諮詢服務及科室升級服務
Listing Date2015-07-08
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市西城區西直門外大街6號中儀大廈9樓
Business Address (Hong Kong)香港灣仔港灣道1號會展廣場辦公大樓3302-3303室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteuniversalmsm.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 8.18 / shares
Offer Price RangeTo be extracted
Lot Size500 shares
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2015-06-24 to 2015-06-29
Global Offering Shares423,189,500 shares
HK Public Offer Shares (Initial)42,319,000 shares (10.0%)
Public Offer Lots (Initial)84,638lots (Pool A42,319lots,Pool B42,319lots)
International Placing Shares (Initial)380,870,500 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,692,755,580 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share11.4%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 3,461,690,110

Stock Connect Inclusion Analysis

Avg Daily HK Mkt Cap HK$ 10.4B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣456.6百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201220132014
Revenue 593,326981,4581,552,682
Cost of sales -204,781-348,619-619,594
Gross profit 388,545632,839933,088
Other income and gains, net 6,39354,88715,419
Selling and distribution expenses -70,296-106,874-126,295
Administrative expenses -77,037-154,395-190,614
Profit before tax 239,148418,344611,082
Income tax expense -61,496-105,606-154,444
Profit for the year 177,652312,738456,638
Profit attributable to owners 177,652312,738456,638
Balance Sheet
Item 201220132014
Cash and cash equivalents 307,980318,998453,569
Inventories 3,7753,3213,119
Total current assets 1,967,4173,170,2104,759,911
Total assets 5,883,44410,452,43416,385,316
Total current liabilities 2,886,5623,992,2505,412,449
Total liabilities 5,027,4419,283,69113,957,817
Total equity 856,0031,168,7432,427,499
Equity attributable to owners 856,0031,168,7432,427,499
Interest-bearing borrowings 3,788,6997,905,81611,408,252
Cash Flow Statement
Item 201220132014
Net cash from operating activities -1,592,904-4,119,417-4,110,715
Net cash from investing activities -60,492-582-741
Net cash from financing activities 1,679,9924,140,8804,247,903
Net increase in cash 26,59620,881136,447
Depreciation of PP&E 8,56016,33915,150
Purchase of PP&E -60,492-582-741
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 5.0
First Day OpenHK$ 6.11
First Day Change-38.88%
First Day Volume74161000.0
First Day Turnover414503000.0
Use of Proceeds
1、約45.0%將用作加強我們的資本資源,以支持我們融資租賃業務的持續發展,主要用于醫療行業; 2、約20.0%將用作開發醫院信息化服務,以配合我們現有的綜合解決方案;我們擬為技術解決方案團隊增聘人手以擴充其陣容,以及開發一套自有的醫院信息管理系統;我們亦計劃獲得有關醫院信息化服務的服務,并于實施醫院信息化服務時將部分所得款項為醫院客戶提供資金; 3、約15.0%將用作發展我們的醫院托管業務; 4、約10.0%將用作進一步發展腦卒中項目解決方案及其他高需求領域用的其他新科室升級服務; 5、約10.0%將作為一般企業用途所需資金。

Underwriting Syndicate

Joint Sponsors (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 Nomura International (Hong Kong) Limited CE AAF742
Overall Coordinators (2)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 Nomura International (Hong Kong) Limited CE AAF742
Joint Bookrunners (7)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 Nomura International (Hong Kong) Limited CE AAF742 ICBC INTERNATIONAL CAPITAL LIMITED CE AQW615 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 建银国际金融有限公司 CE AJO225 VMS Securities Limited CE AAC621 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Lead Managers (7)
GOLDMAN SACHS (ASIA) L.L.C. CE ACC536 Nomura International (Hong Kong) Limited CE AAF742 ICBC INTERNATIONAL CAPITAL LIMITED CE AQW615 ICBC INTERNATIONAL SECURITIES LIMITED CE ARO299 建银国际金融有限公司 CE AJO225 VMS Securities Limited CE AAC621 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Estate Summer Limited 77,513,680 HKD — 0.60% — 6 months 2016-01-08
2 Heywin Investments Limited 77,513,680 HKD — 0.60% — 6 months 2016-01-08
3 Nikko Asset Management Asia Limited 155,035,540 HKD — 1.10% — 6 months 2016-01-08
4 Yi Fang Da Elite Inv. Limited 232,557,400 HKD — 1.70% — 6 months 2016-01-08
5 北京慈航投资基金管理有限公司 232,557,400 HKD — 1.70% — 6 months 2016-01-08
6 广发基金管理有限公司 232,557,400 HKD — 1.70% — 6 months 2016-01-08
7 恒健国际投资控股(香港)有限公司 77,513,680 HKD — 0.60% — 6 months 2016-01-08
8 京投(香港)有限公司 155,035,540 HKD — 1.10% — 6 months 2016-01-08
9 中国南车(香港)有限公司 232,557,400 HKD — 1.70% — 6 months 2016-01-08
10 中新融创资本管理有限公司 77,513,680 HKD — 0.60% — 6 months 2016-01-08

Directors & Management

PositionChinese nameEnglish Name
Chairman陳仕俗—
Company Secretary鄭碧玉—
No director data available.

Major Shareholders

Major Shareholders & Holdings通用技術集團(透過香港資本及通用諮詢香港)合共持股38.25%;中信資本持股14.43%;工銀國際持股7.16%;捷道有限公司持股5.70%(由周大福企業有限公司最終擁有)
About this page

This page shows Uni Medical (02666) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect